Patient-Specificity Meets Digital Ecosystems As Corin Acquires TKR Robotics Player Omni

Hip and knee replacement challenger firm Corin Group has a big ambition to revolutionize orthopedics with connected digital ecosystems and patient-specific concepts. That aim has come a step closer with its acquisition of robotic-assisted total knee replacement (TKR) company Omni Orthopaedics. Corin's Elvio Gramignano believes this approach will lead to real change in health care delivery.       

Business merger
• Source: Shutterstock

The private equity-backed hip and knee implant company, Corin Group PLC, has taken its patient-centered, value-based strategy to another level, with the purchase of Omni Orthopaedics Inc. The US-based company specializes in robotic-assisted total knee replacement (TKR), using its OmniBotics robot, OmniBot cutting guide and BalanceBot tool to measure ligament function.

The transaction value was not disclosed, but it is Corin’s biggest acquisition to date, and a “pivotal” buy, the company’s...

More from Innovation

More from In Vivo

Deals In Depth: June 2025

 
• By 

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By 

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By 

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.